Skip to main content

Animations

MJFF Publications

7181 - 7190 of 8808 Results
Title
Year
  • Year
  • 2025
  • 2020
  • 2024
  • 2006
  • 2013
  • 2015
  • 2016
  • 2016
  • 2020
  • 2023
  • Summary Details
    OPEN
    Title: Alpha-synuclein abundance and localization are regulated by the RNA-binding protein PUMILIO1
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.celrep.2025.116145
    Citation Count: 1
  • Summary Details
    OPEN
    Title: An Increased Burden of Highly Active Retrotransposition Competent L1s Is Associated with Parkinson’s Disease Risk and Progression in the PPMI Cohort
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms21186562
    Citation Count: 33
  • Summary Details
    OPEN
    Title: Disruption of the LRRK2‐FADD Interface Using Constrained Peptides
    Journal Name: Peptide Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/pep2.24374
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Characterization of intracellular elevation of glutathione (GSH) with glutathione monoethyl ester and GSH in brain and neuronal cultures: Relevance to Parkinson's disease
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2006.09.004
    Citation Count: 97
  • Summary Details
    RESTRICTED
    Title: 5-Hydroxy-tryptophan for the treatment of l-DOPA-induced dyskinesia in the rat Parkinson's disease model
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2013.08.014
    Citation Count: 52
  • Summary Details
    RESTRICTED
    Title: The link between mitochondrial complex I and brain-derived neurotrophic factor in SH-SY5Y cells – The potential of JNX1001 as a therapeutic agent
    Journal Name: European Journal of Pharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.ejphar.2015.07.013
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Phos-tag analysis of Rab10 phosphorylation by LRRK2: a powerful assay for assessing kinase function and inhibitors
    Journal Name: Biochemical Journal
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1042/bcj20160557
    Citation Count: 170
  • Summary Details
    OPEN
    Title: No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-016-0130-3
    Citation Count: 21
  • Summary Details
    RESTRICTED
    Title: Carepartner Communication on Parkinson Disease Psychosis (4116)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4116
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Cerebral white matter rarefaction has both neurodegenerative and vascular causes and may primarily be a distal axonopathy
    Journal Name: Journal of Neuropathology & Experimental Neurology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/jnen/nlad026
    Citation Count: 13
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.